Align Technology, Inc. $ALGN Stake Lessened by Hudson Bay Capital Management LP

Hudson Bay Capital Management LP lessened its holdings in Align Technology, Inc. (NASDAQ:ALGN) by 78.8% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 43,440 shares of the medical equipment provider’s stock after selling 161,627 shares during the quarter. Hudson Bay Capital Management LP’s holdings in Align Technology were worth $5,440,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of ALGN. Sentry Investment Management LLC raised its position in Align Technology by 73.1% during the third quarter. Sentry Investment Management LLC now owns 187 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 79 shares during the period. Steigerwald Gordon & Koch Inc. acquired a new stake in Align Technology during the 3rd quarter worth about $26,000. Quent Capital LLC acquired a new stake in Align Technology during the 3rd quarter worth about $30,000. TD Private Client Wealth LLC grew its stake in Align Technology by 135.6% during the 3rd quarter. TD Private Client Wealth LLC now owns 238 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 137 shares in the last quarter. Finally, JFS Wealth Advisors LLC grew its stake in Align Technology by 2,016.7% during the 3rd quarter. JFS Wealth Advisors LLC now owns 254 shares of the medical equipment provider’s stock valued at $32,000 after acquiring an additional 242 shares in the last quarter. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Insider Activity at Align Technology

In related news, EVP John Morici sold 7,969 shares of the firm’s stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $189.31, for a total value of $1,508,611.39. Following the transaction, the executive vice president directly owned 8,237 shares of the company’s stock, valued at approximately $1,559,346.47. This trade represents a 49.17% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.66% of the company’s stock.

Align Technology Trading Down 1.7%

Shares of NASDAQ:ALGN opened at $173.18 on Friday. The stock has a market capitalization of $12.34 billion, a PE ratio of 30.60, a P/E/G ratio of 1.92 and a beta of 1.79. Align Technology, Inc. has a 1 year low of $122.00 and a 1 year high of $208.30. The firm has a fifty day moving average price of $176.55 and a 200 day moving average price of $154.27.

Align Technology (NASDAQ:ALGN) last posted its earnings results on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share for the quarter, beating the consensus estimate of $2.99 by $0.30. Align Technology had a return on equity of 15.16% and a net margin of 10.17%.The company had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same period last year, the company earned $2.44 earnings per share. The business’s revenue was up 5.3% compared to the same quarter last year. On average, sell-side analysts forecast that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Key Align Technology News

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Elliott Investment Management has built a significant, reportedly “major” stake in Align, signalling potential engagement to push for actions that could boost shareholder value (strategic review, cost moves, buybacks or governance changes). This is the primary catalyst behind recent intraday upside. Elliott builds stake in Invisalign maker Align Technology – Reuters
• Positive Sentiment: Market coverage notes and press reports (Bloomberg/Yahoo) echo the stake build and include an updated company response — the combination of activist pressure plus public attention is often perceived as positive for near-term shareholder returns. Market Chatter: Activist Elliott Investment Builds Stake in Align Technology – Yahoo
• Positive Sentiment: Analyst/market reaction: ALGN saw premarket and intraday spikes on the reports and a recent upgrade to Overweight at Barclays, which may lend support to the stock if analysts follow with higher targets. Align Technology Raised to Overweight at Barclays – American Banking News
• Neutral Sentiment: Short interest posts in the data feed show zero shares (and 0 days to cover), which appears to be a reporting anomaly rather than a market signal — treat short-interest headlines with caution until clean data is published.
• Negative Sentiment: Structural headwinds remain: ALGN is still materially below its 2021 peak as dental/demand trends have normalized after the pandemic-era boom. Activist involvement can be positive but may also lead to strategic changes that create uncertainty or execution risk in the near term. Elliott Builds Major Align Stake as Shares Sit Near $172 – Yahoo

Analysts Set New Price Targets

A number of research firms have recently issued reports on ALGN. Piper Sandler increased their price target on shares of Align Technology from $200.00 to $220.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Mizuho boosted their price objective on shares of Align Technology from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. Robert W. Baird set a $218.00 price objective on shares of Align Technology in a research note on Thursday, February 5th. Barclays upgraded shares of Align Technology from an “equal weight” rating to an “overweight” rating and set a $200.00 target price for the company in a research report on Tuesday. Finally, Weiss Ratings raised shares of Align Technology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, January 16th. Seven equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Align Technology presently has an average rating of “Moderate Buy” and a consensus target price of $198.08.

About Align Technology

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.